Answers are grounded in this paper and cite their sources.
DC-SIGN, a lectin discovered two decades ago, plays a relevant role in innate immunity. Since its discovery, it has turned out to be a target for developing antiviral drugs based on carbohydrates due to its participation in the infection process of several pathogens. A plethora of carbohydrate multivalent systems using different scaffolds have been described to achieve this goal. Our group has made significant contributions to this field, which are revised herein.
No takes yet. Share an insight, caveat, or question.
Ramos‐Soriano et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: